MarginsXMarginsX
Home › Markets › Health Care › AEON

AEON Biopharma Inc. (AEON)

AEON trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.1407
-8.04% on the day
Market cap
$10.1M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerAEON on NYSE
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001837607
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
3.0 months
$3.4M cash at June 30, 2026
Share count, 1 year
+4184.1%
2025-08-08 to 2026-08-06 · +9565.2% over 3 years
Going-concern doubt
Yes
10-Q filed August 12, 2026
Insider net buying, 12 months
$242K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As a result of these conditions, management has concluded that there is substantial doubt about the Company's ability to continue as a going concern and to meet its obligations as they become due within one year after the date that these condensed consolidated financial statements are issued."
10-Q 2026-08-12
Cash and burn$3.4M cash; operating cash flow -$3.4M a quarter.Report 2026-06-30
Shares outstanding49,882,790 (2026-08-06); 1,164,378 a year earlier; 37,159,600 three years earlier. 3y figure adjusted for split (1-for-72 overall).Cover page 2026-08-06
Reverse splits, 3 years1; latest 1-for-72 on 2025-02-26Source 2025-02-26
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-02-09
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-04-03
AuditorKPMG LLP, San Diego, California, United StatesPCAOB Form AP 2026-04-22
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $242K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$1.2M-$3.7M$3.4MNo debt tagsNeeds four quarters10-Q 2026-08-12
Q1 2026
2026-03-31
Not filed-$11.8M-$2.6M$6.2MNo debt tagsNeeds four quarters10-Q 2026-05-14
Q4 2025
2025-12-31
Not filed-$37.1M-$4.7M$3.0MNo debt tagsNeeds four quarters10-K 2026-03-30
Q3 2025
2025-09-30
Not filed-$4.5M-$2.6M$5.9MNo debt tagsNeeds four quarters10-Q 2025-11-14
Q2 2025
2025-06-30
Not filed-$6.6M-$2.1M$8.4MNo debt tagsNeeds four quarters10-Q 2026-08-12
Q1 2025
2025-03-31
Not filed$9.1M-$7.9M$10.4MNo debt tagsNeeds four quarters10-Q 2026-05-14
Q4 2024
2024-12-31
Not filed$2.1M-$621K$13KNo debt tagsNeeds four quarters10-K 2026-03-30
Q3 2024
2024-09-30
Not filed-$6.2M-$3.0M$537KNo debt tagsNeeds four quarters10-Q 2025-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-11-03
Latest annual report10-K2026-03-30
Latest quarterly / interim10-Q2026-08-12
Latest current report8-K2026-11-16
Latest proxyDEF 14A2026-10-26

Source: SEC EDGAR submissions feed, 365 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-13.1%
1 month-33.5%
3 months-43.5%
Year to date-86.1%
1 year-83.7%
From 52-week high-88.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
CLRBCellectar Biosciences Inc.$1.01-11.40%$10.1M
BFRIBiofrontera Inc.$0.5700-18.58%$10.2M
HINDVyome Holdings Inc.$1.53-3.16%$10.7M
LEXXLexaria Bioscience Corp.$4.41-0.68%$9.3M
PTNPalatin Technologies Inc.$6.13-1.69%$10.9M
GDTCCytoMed Therapeutics Limited$0.7739-6.68%$9.2M
RADXRadiopharm Theranostics Limited$0.7676+1.00%$11.1M
BFRGBullfrog AI Holdings Inc.$0.4878-9.92%$9.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier